Global, regional, and national burden of heart failure and its risk factors between 1990 and 2021 and projections to 2050: an analysis of the global burden of disease study
Authors:
Open Access
- 8 July 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
- Vol. 11 (7) , 1144-1154
Abstract
Aims: At present, there is a lack of recent heart failure (HF) epidemiological data up to 2021. This study aims to assess the HF burden and its risk factors from 1990 to 2021 and project trends to 2050. Methods and results: We derived HF prevalence and years lived with disability (YLDs) from Global Burden of Disease Study 2021, performing subgroup analyses by sex, age, sociodemographic index (SDI), and regions. Health inequalities were measured using the Inequality Slope Index and Concentration Index. Additionally, we made a decomposition analysis of the HF burden and forecasted its impact by 2050. The global age-standardized prevalence rate (ASPR) and age-standardized YLD rate (ASYR) of HF were 676.68 (95% UI: 598.68–776.84) and 64.7 (95% UI: 44.2–89.47) per 100 000 people and increased by 5.5% and 5.9% from 1990 to 2021, respectively. The ASPR and ASYR were higher in regions in the relatively higher SDI quintile, while the HF burden in regions in the lower SDI quintile is increasing. Ischaemic heart disease accounted for the highest ASPR of HF globally [244.02 (95% UI: 179.09–322.13)], followed by hypertensive heart disease [148.32 (95% UI: 117.32–186.28)]. The ASPR and ASYR of HF are projected to rise from 2022 to 2050, with males dominating. Conclusion: The escalating HF burden represents a critical public health challenge, necessitating immediate intervention. Policymakers must devise precise strategies aimed at curbing and preventing the HF burden.Keywords
Funding Information
- Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0504600)
- National High-level hospital clinical research Funding (BJYY-2023-070)
- CAMS Innovation Fund for Medical Sciences (2021-I2M-1-050)
This publication has 43 references indexed in Scilit:
- Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial InfarctionCurrent Cardiology Reports, 2022
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Journal of Heart Failure, 2022
- Sedentary behavior and health outcomes in patients with heart failure: a systematic review and meta-analysisHeart Failure Reviews, 2021
- The Heart Failure Association Atlas : Heart Failure Epidemiology and Management Statistics 2019European Journal of Heart Failure, 2021
- Epidemiology of Heart Failure: Study of Heart Failure in the Australian Primary CarE Setting (SHAPE)ESC Heart Failure, 2020
- Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiersHeart Failure Reviews, 2020
- Heart failure in adult congenital heart disease: tetralogy of FallotHeart Failure Reviews, 2020
- Epidemiology of Heart Failure: The Prevalence of Heart Failure and Ventricular Dysfunction in Older Adults Over Time. a Systematic ReviewEuropean Journal of Heart Failure, 2016
- Sex-Dependent Regulation of Fibrosis and Inflammation in Human Left Ventricular Remodelling Under Pressure OverloadEuropean Journal of Heart Failure, 2014
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000